[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 252 Engrossed Amendment House (EAH)]

                In the House of Representatives, U. S.,

                                                     November 12, 2013.
    Resolved, That the bill from the Senate (S. 252) entitled ``An Act 
to reduce preterm labor and delivery and the risk of pregnancy-related 
deaths and complications due to pregnancy, and to reduce infant 
mortality caused by prematurity.'', do pass with the following

                              AMENDMENTS:

            Strike out all after the enacting clause and insert:

SECTION 1. TABLE OF CONTENTS.

    The table of contents for this Act is as follows:

Sec. 1. Table of contents.

                  TITLE I--PREEMIE ACT REAUTHORIZATION

Sec. 101. Short title.
Sec. 102. Research and activities at the Centers for Disease Control 
                            and Prevention.
Sec. 103. Activities at the Health Resources and Services 
                            Administration.
Sec. 104. Other activities.

             TITLE II--NATIONAL PEDIATRIC RESEARCH NETWORK

Sec. 201. Short title.
Sec. 202. National Pediatric Research Network.

                    TITLE III--CHIMP ACT AMENDMENTS

Sec. 301. Short title.
Sec. 302. Care for NIH chimpanzees.

                  TITLE I--PREEMIE ACT REAUTHORIZATION

SEC. 101. SHORT TITLE.

    This title may be cited as the ``Prematurity Research Expansion and 
Education for Mothers who deliver Infants Early Reauthorization Act'' 
or the ``PREEMIE Reauthorization Act''.

SEC. 102. RESEARCH AND ACTIVITIES AT THE CENTERS FOR DISEASE CONTROL 
              AND PREVENTION.

    (a) Epidemiological Studies.--Section 3 of the Prematurity Research 
Expansion and Education for Mothers who deliver Infants Early Act (42 
U.S.C. 247b-4f) is amended by striking subsection (b) and inserting the 
following:
    ``(b) Studies and Activities on Preterm Birth.--
            ``(1) In general.--The Secretary of Health and Human 
        Services, acting through the Director of the Centers for 
        Disease Control and Prevention, may, subject to the 
        availability of appropriations--
                    ``(A) conduct epidemiological studies on the 
                clinical, biological, social, environmental, genetic, 
                and behavioral factors relating to prematurity, as 
                appropriate;
                    ``(B) conduct activities to improve national data 
                to facilitate tracking the burden of preterm birth; and
                    ``(C) continue efforts to prevent preterm birth, 
                including late preterm birth, through the 
                identification of opportunities for prevention and the 
                assessment of the impact of such efforts.
            ``(2) Report.--Not later than 2 years after the date of 
        enactment of the PREEMIE Reauthorization Act, and every 2 years 
        thereafter, the Secretary of Health and Human Services, acting 
        through the Director of the Centers for Disease Control and 
        Prevention, shall submit to the appropriate committees of 
        Congress reports concerning the progress and any results of 
        studies conducted under paragraph (1).''.
    (b) Reauthorization.--Section 3(e) of the Prematurity Research 
Expansion and Education for Mothers who deliver Infants Early Act (42 
U.S.C. 247b-4f(e)) is amended by striking ``$5,000,000'' and all that 
follows through ``2011.'' and inserting ``$1,880,000 for each of fiscal 
years 2014 through 2018.''.

SEC. 103. ACTIVITIES AT THE HEALTH RESOURCES AND SERVICES 
              ADMINISTRATION.

    (a) Telemedicine and High-Risk Pregnancies.--Section 330I(i)(1)(B) 
of the Public Health Service Act (42 U.S.C. 254c-14(i)(1)(B)) is 
amended by striking ``or case management services'' and inserting 
``case management services, or prenatal care for high-risk 
pregnancies'';
    (b) Public and Health Care Provider Education.--Section 399Q of the 
Public Health Service Act (42 U.S.C. 280g-5) is amended--
            (1) in subsection (b)--
                    (A) in paragraph (1), by striking subparagraphs (A) 
                through (F) and inserting the following:
                    ``(A) the core risk factors for preterm labor and 
                delivery;
                    ``(B) medically indicated deliveries before full 
                term;
                    ``(C) the importance of preconception and prenatal 
                care, including--
                            ``(i) smoking cessation;
                            ``(ii) weight maintenance and good 
                        nutrition, including folic acid;
                            ``(iii) the screening for and the treatment 
                        of infections; and
                            ``(iv) stress management;
                    ``(D) treatments and outcomes for premature 
                infants, including late preterm infants;
                    ``(E) the informational needs of families during 
                the stay of an infant in a neonatal intensive care 
                unit; and
                    ``(F) utilization of evidence-based strategies to 
                prevent birth injuries;''; and
                    (B) by striking paragraph (2) and inserting the 
                following:
            ``(2) programs to increase the availability, awareness, and 
        use of pregnancy and post-term information services that 
        provide evidence-based, clinical information through 
        counselors, community outreach efforts, electronic or 
        telephonic communication, or other appropriate means regarding 
        causes associated with prematurity, birth defects, or health 
        risks to a post-term infant;''; and
            (2) in subsection (c), by striking ``$5,000,000'' and all 
        that follows through ``2011.'' and inserting ``$1,900,000 for 
        each of fiscal years 2014 through 2018.''.

SEC. 104. OTHER ACTIVITIES.

    (a) Interagency Coordinating Council on Prematurity and Low 
Birthweight.--The Prematurity Research Expansion and Education for 
Mothers who deliver Infants Early Act is amended by striking section 5 
(42 U.S.C. 247b-4g).
    (b) Advisory Committee on Infant Mortality.--
            (1) Establishment.--The Secretary of Health and Human 
        Services (referred to in this section as the ``Secretary'') may 
        establish an advisory committee known as the ``Advisory 
        Committee on Infant Mortality'' (referred to in this section as 
        the ``Advisory Committee'').
            (2) Duties.--The Advisory Committee shall provide advice 
        and recommendations to the Secretary concerning the following 
        activities:
                    (A) Programs of the Department of Health and Human 
                Services that are directed at reducing infant mortality 
                and improving the health status of pregnant women and 
                infants.
                    (B) Strategies to coordinate the various Federal 
                programs and activities with State, local, and private 
                programs and efforts that address factors that affect 
                infant mortality.
                    (C) Implementation of the Healthy Start program 
                under section 330H of the Public Health Service Act (42 
                U.S.C. 254c-8) and Healthy People 2020 infant mortality 
                objectives.
                    (D) Strategies to reduce preterm birth rates 
                through research, programs, and education.
            (3) Plan for hhs preterm birth activities.--Not later than 
        1 year after the date of enactment of this section, the 
        Advisory Committee (or an advisory committee in existence as of 
        the date of enactment of this Act and designated by the 
        Secretary) shall develop a plan for conducting and supporting 
        research, education, and programs on preterm birth through the 
        Department of Health and Human Services and shall periodically 
        review and revise the plan, as appropriate. The plan shall--
                    (A) examine research and educational activities 
                that receive Federal funding in order to enable the 
                plan to provide informed recommendations to reduce 
                preterm birth and address racial and ethnic disparities 
                in preterm birth rates;
                    (B) identify research gaps and opportunities to 
                implement evidence-based strategies to reduce preterm 
                birth rates among the programs and activities of the 
                Department of Health and Human Services regarding 
                preterm birth, including opportunities to minimize 
                duplication; and
                    (C) reflect input from a broad range of scientists, 
                patients, and advocacy groups, as appropriate.
            (4) Membership.--The Secretary shall ensure that the 
        membership of the Advisory Committee includes the following:
                    (A) Representatives provided for in the original 
                charter of the Advisory Committee.
                    (B) A representative of the National Center for 
                Health Statistics.
    (c) Patient Safety Studies and Report.--
            (1) In general.--The Secretary shall designate an 
        appropriate agency within the Department of Health and Human 
        Services to coordinate existing studies on hospital 
        readmissions of preterm infants.
            (2) Report to secretary and congress.--Not later than 1 
        year after the date of the enactment of this Act, the agency 
        designated under paragraph (1) shall submit to the Secretary 
        and to Congress a report containing the findings and 
        recommendations resulting from the studies coordinated under 
        such paragraph, including recommendations for hospital 
        discharge and followup procedures designed to reduce rates of 
        preventable hospital readmissions for preterm infants.

             TITLE II--NATIONAL PEDIATRIC RESEARCH NETWORK

SEC. 201. SHORT TITLE.

    This title may be cited as the ``National Pediatric Research 
Network Act of 2013''.

SEC. 202. NATIONAL PEDIATRIC RESEARCH NETWORK.

    Section 409D of the Public Health Service Act (42 U.S.C. 284h; 
relating to the Pediatric Research Initiative) is amended--
            (1) by redesignating subsection (d) as subsection (f); and
            (2) by inserting after subsection (c) the following:
    ``(d) National Pediatric Research Network.--
            ``(1) Network.--In carrying out the Initiative, the 
        Director of NIH, in consultation with the Director of the 
        Eunice Kennedy Shriver National Institute of Child Health and 
        Human Development and in collaboration with other appropriate 
        national research institutes and national centers that carry 
        out activities involving pediatric research, may provide for 
        the establishment of a National Pediatric Research Network in 
        order to more effectively support pediatric research and 
        optimize the use of Federal resources. Such National Pediatric 
        Research Network may be comprised of, as appropriate--
                    ``(A) the pediatric research consortia receiving 
                awards under paragraph (2); or
                    ``(B) other consortia, centers, or networks focused 
                on pediatric research that are recognized by the 
                Director of NIH and established pursuant to the 
                authorities vested in the National Institutes of Health 
                by other sections of this Act.
            ``(2) Pediatric research consortia.--
                    ``(A) In general.--The Director of NIH may award 
                funding, including through grants, contracts, or other 
                mechanisms, to public or private nonprofit entities for 
                providing support for pediatric research consortia, 
                including with respect to--
                            ``(i) basic, clinical, behavioral, or 
                        translational research to meet unmet needs for 
                        pediatric research; and
                            ``(ii) training researchers in pediatric 
                        research techniques in order to address unmet 
                        pediatric research needs.
                    ``(B) Research.--The Director of NIH shall, as 
                appropriate, ensure that--
                            ``(i) each consortium receiving an award 
                        under subparagraph (A) conducts or supports at 
                        least one category of research described in 
                        subparagraph (A)(i) and collectively such 
                        consortia conduct or support such categories of 
                        research; and
                            ``(ii) one or more such consortia provide 
                        training described in subparagraph (A)(ii).
                    ``(C) Organization of consortium.--Each consortium 
                receiving an award under subparagraph (A) shall--
                            ``(i) be formed from a collaboration of 
                        cooperating institutions;
                            ``(ii) be coordinated by a lead institution 
                        or institutions;
                            ``(iii) agree to disseminate scientific 
                        findings, including from clinical trials, 
                        rapidly and efficiently, as appropriate, to--
                                    ``(I) other consortia;
                                    ``(II) the National Institutes of 
                                Health;
                                    ``(III) the Food and Drug 
                                Administration;
                                    ``(IV) and other relevant agencies; 
                                and
                            ``(iv) meet such requirements as may be 
                        prescribed by the Director of NIH.
                    ``(D) Supplement, not supplant.--Any support 
                received by a consortium under subparagraph (A) shall 
                be used to supplement, and not supplant, other public 
                or private support for activities authorized to be 
                supported under this paragraph.
                    ``(E) Duration of support.--Support of a consortium 
                under subparagraph (A) may be for a period of not to 
                exceed 5 years. Such period may be extended at the 
                discretion of the Director of NIH.
            ``(3) Coordination of consortia activities.--The Director 
        of NIH shall, as appropriate--
                    ``(A) provide for the coordination of activities 
                (including the exchange of information and regular 
                communication) among the consortia established pursuant 
                to paragraph (2); and
                    ``(B) require the periodic preparation and 
                submission to the Director of reports on the activities 
                of each such consortium.
            ``(4) Assistance with registries.--Each consortium 
        receiving an award under paragraph (2)(A) may provide 
        assistance, as appropriate, to the Centers for Disease Control 
        and Prevention for activities related to patient registries and 
        other surveillance systems upon request by the Director of the 
        Centers for Disease Control and Prevention.
    ``(e) Research on Pediatric Rare Diseases or Conditions.--In making 
awards under subsection (d)(2) for pediatric research consortia, the 
Director of NIH shall ensure that an appropriate number of such awards 
are awarded to such consortia that agree to--
            ``(1) consider pediatric rare diseases or conditions, or 
        those related to birth defects; and
            ``(2) conduct or coordinate one or more multisite clinical 
        trials of therapies for, or approaches to, the prevention, 
        diagnosis, or treatment of one or more pediatric rare diseases 
        or conditions.''.

                    TITLE III--CHIMP ACT AMENDMENTS

SEC. 301. SHORT TITLE.

    This title may be cited as the ``CHIMP Act Amendments of 2013''.

SEC. 302. CARE FOR NIH CHIMPANZEES.

    (a) In General.--Section 404K(g) of the Public Health Service Act 
(42 U.S.C. 283m(g)) is amended--
            (1) by amending paragraph (1) to read as follows:
            ``(1) In general.--Of the amount appropriated for the 
        National Institutes of Health, there are authorized to be 
        appropriated to carry out this section and for the care, 
        maintenance, and transportation of all chimpanzees otherwise 
        under the ownership or control of the National Institutes of 
        Health, and to enable the National Institutes of Health to 
        operate more efficiently and economically by decreasing the 
        overall Federal cost of providing for the care, maintenance, 
        and transportation of chimpanzees--
                    ``(A) for fiscal year 2014, $12,400,000;
                    ``(B) for fiscal year 2015, $11,650,000;
                    ``(C) for fiscal year 2016, $10,900,000;
                    ``(D) for fiscal year 2017, $10,150,000; and
                    ``(E) for fiscal year 2018, $9,400,000.'';
            (2) by striking paragraph (2);
            (3) by redesignating paragraph (3) as paragraph (2); and
            (4) in paragraph (2), as so redesignated--
                    (A) by striking ``With respect to amounts reserved 
                under paragraph (1)'' and inserting ``With respect to 
                amounts authorized to be appropriated by paragraph 
                (1)''; and
                    (B) by striking ``board of directors'' and 
                inserting ``Secretary in consultation with the board of 
                directors''.
    (b) GAO Study.--Not later than 2 years after the date of enactment 
of this Act, the Comptroller General of the United States shall conduct 
an independent evaluation, and submit to the appropriate committees of 
Congress a report, regarding chimpanzees under the ownership or control 
the National Institutes of Health. Such report shall review and 
assess--
            (1) the research status of such chimpanzees;
            (2) the cost for the care, maintenance, and transportation 
        of such chimpanzees, including the cost broken down by--
                    (A) research or retirement status;
                    (B) services included in the care, maintenance, and 
                transportation; and
                    (C) location;
            (3) the extent to which matching requirements have been met 
        pursuant to section 404K(e)(4) of the Public Health Service Act 
        (42 U.S.C. 283m(e)(4)); and
            (4) any options for cost savings for the support and 
        maintenance of such chimpanzees.
    (c) Biennial Report.--Section 404K(g) of the Public Health Service 
Act (42 U.S.C. 283m(g)) is amended by adding at the end the following:
            ``(3) Biennial report.--Not later than 180 days after the 
        date enactment of this Act, the Director of the National 
        Institutes of Health shall submit to the Committee on Health, 
        Education, Labor, and Pensions and the Committee on 
        Appropriations of the Senate and the Committee on Energy and 
        Commerce and the Committee on Appropriations in the House of 
        Representatives a report, to be updated biennially, regarding--
                    ``(A) the care, maintenance, and transportation of 
                the chimpanzees under the ownership or control of the 
                National Institutes of Health;
                    ``(B) costs related to such care, maintenance, and 
                transportation, and any other related costs; and
                    ``(C) the research status of such chimpanzees.''.

            Amend the title so as to read: ``An Act to reduce preterm 
        labor and delivery and the risk of pregnancy-related deaths and 
        complications due to pregnancy, and to reduce infant mortality 
        caused by prematurity, and for other purposes.''.

            Attest:

                                                                 Clerk.
113th CONGRESS

  1st Session

                                 S. 252

_______________________________________________________________________

                               AMENDMENTS